Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 735.10
-19.50 (-2.58%)
At close: May 29, 2026
Alembic Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 144,690 | 130,370 | 182,755 | 193,575 | 97,564 | 145,771 | |
Market Cap Growth | -18.28% | -28.66% | -5.59% | 98.41% | -33.07% | -23.15% |
Enterprise Value | 156,904 | 143,795 | 192,124 | 200,785 | 104,548 | 151,109 |
Last Close Price | 735.10 | 661.85 | 919.07 | 960.73 | 479.74 | 706.21 |
PE Ratio | 21.44 | 19.32 | 31.33 | 31.43 | 28.53 | 27.98 |
PS Ratio | 1.97 | 1.78 | 2.74 | 3.11 | 1.73 | 2.75 |
PB Ratio | 2.55 | 2.30 | 3.52 | 4.02 | 2.23 | 2.78 |
P/TBV Ratio | 2.69 | 2.42 | 3.52 | 4.02 | 2.23 | 2.87 |
P/FCF Ratio | 41.56 | 37.45 | - | 40.69 | 34.78 | 115.04 |
P/OCF Ratio | 18.49 | 16.66 | 207.75 | 24.10 | 13.48 | 26.39 |
EV/Sales Ratio | 2.14 | 1.96 | 2.88 | 3.22 | 1.85 | 2.85 |
EV/EBITDA Ratio | 14.03 | 12.86 | 19.42 | 21.97 | 15.02 | 17.60 |
EV/EBIT Ratio | 19.61 | 17.98 | 26.33 | 30.39 | 23.88 | 25.72 |
EV/FCF Ratio | 45.07 | 41.31 | - | 42.21 | 37.27 | 119.26 |
Debt / Equity Ratio | 0.25 | 0.25 | 0.24 | 0.11 | 0.17 | 0.14 |
Debt / EBITDA Ratio | 1.28 | 1.28 | 1.25 | 0.55 | 1.01 | 0.82 |
Debt / FCF Ratio | 4.11 | 4.11 | - | 1.08 | 2.57 | 5.66 |
Net Debt / Equity Ratio | 0.22 | 0.22 | 0.23 | 0.08 | 0.15 | 0.13 |
Net Debt / EBITDA Ratio | 1.10 | 1.10 | 1.19 | 0.43 | 0.93 | 0.76 |
Net Debt / FCF Ratio | 3.53 | 3.53 | -2.47 | 0.83 | 2.31 | 5.18 |
Asset Turnover | 0.89 | 0.89 | 0.94 | 0.99 | 0.85 | 0.77 |
Inventory Turnover | 0.83 | 0.83 | 0.96 | 1.15 | 1.15 | 0.97 |
Quick Ratio | 0.65 | 0.65 | 0.62 | 0.82 | 0.74 | 0.52 |
Current Ratio | 1.76 | 1.76 | 1.70 | 2.12 | 1.78 | 1.67 |
Return on Equity (ROE) | 12.36% | 12.36% | 11.63% | 13.40% | 7.12% | 10.11% |
Return on Assets (ROA) | 6.05% | 6.05% | 6.42% | 6.54% | 4.11% | 5.31% |
Return on Invested Capital (ROIC) | 11.41% | 11.66% | 10.38% | 12.59% | 7.74% | 8.69% |
Return on Capital Employed (ROCE) | 13.00% | 13.00% | 13.60% | 13.20% | 9.60% | 10.90% |
Earnings Yield | 4.66% | 5.18% | 3.19% | 3.18% | 3.50% | 3.57% |
FCF Yield | 2.41% | 2.67% | -2.60% | 2.46% | 2.88% | 0.87% |
Dividend Yield | 1.45% | 1.81% | 1.20% | 1.15% | 1.67% | 1.42% |
Payout Ratio | 32.04% | 32.04% | 37.06% | 25.54% | 57.48% | 52.83% |
Buyback Yield / Dilution | 0.01% | 0.01% | - | - | - | -1.46% |
Total Shareholder Return | 1.45% | 1.82% | 1.20% | 1.15% | 1.67% | -0.04% |